Mirum Pharmaceuticals said on Monday its experimental adjuvant therapy to treat a type of liver disease did not meet main goal in mid-stage study.
https://finance.yahoo.com/news/mirum-pharmas-liver-disease-therapy-133725912.html
Mirum Pharmaceuticals said on Monday its experimental adjuvant therapy to treat a type of liver disease did not meet main goal in mid-stage study.
https://finance.yahoo.com/news/mirum-pharmas-liver-disease-therapy-133725912.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.